Lack of bioeffects of ultrasound energy after intravenous administration of FS069 (Optison) in the anesthetized rabbit - PubMed (original) (raw)
Lack of bioeffects of ultrasound energy after intravenous administration of FS069 (Optison) in the anesthetized rabbit
A L Killam et al. J Ultrasound Med. 1998 Jun.
Abstract
The current study was designed to provide a sensitive in vivo model to maximize the potential bioeffects (measured by hemolysis) of B-mode ultrasound energy in combination with FS069 (Optison). B-mode ultrasound energy was delivered to anesthetized male New Zealand white rabbits with a phased array 5 MHz transducer on a Hewlett-Packard Sonos 1500 ultrasonograph, with transmit level set to maximum (40 dB, approx 135 W/cm2). FS069 (Optison), latex particles in human albumin, or human albumin alone (vehicle) was infused via an ear vein at 0.6 mL/kg. No statistically significant changes were noted in serum free hemoglobin or lactate dehydrogenase either over time or between groups.
Similar articles
- Enhancement of ultrasonically-induced hemolysis by perfluorocarbon-based compared to air-based echo-contrast agents.
Miller DL, Gies RA. Miller DL, et al. Ultrasound Med Biol. 1998 Feb;24(2):285-92. doi: 10.1016/s0301-5629(97)00267-6. Ultrasound Med Biol. 1998. PMID: 9550187 - Intravascular inertial cavitation activity detection and quantification in vivo with Optison.
Tu J, Hwang JH, Matula TJ, Brayman AA, Crum LA. Tu J, et al. Ultrasound Med Biol. 2006 Oct;32(10):1601-9. doi: 10.1016/j.ultrasmedbio.2006.07.015. Ultrasound Med Biol. 2006. PMID: 17045881 - Inertial cavitation dose and hemolysis produced in vitro with or without Optison.
Chen WS, Brayman AA, Matula TJ, Crum LA. Chen WS, et al. Ultrasound Med Biol. 2003 May;29(5):725-37. doi: 10.1016/s0301-5629(03)00013-9. Ultrasound Med Biol. 2003. PMID: 12754072 - Ultrasound contrast. Oral and i.v. agents amplify the image.
Barr RG. Barr RG. Diagn Imaging (San Franc). 1999 Mar;21(3):56-61. Diagn Imaging (San Franc). 1999. PMID: 10351114 Review. No abstract available. - Section 6--mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine.
[No authors listed] [No authors listed] J Ultrasound Med. 2000 Feb;19(2):120-42, 154-68. doi: 10.7863/jum.2000.19.2.120. J Ultrasound Med. 2000. PMID: 10680618 Free PMC article. Review.
Cited by
- Perspective on ultrasound bioeffects and possible implications for continuous post-dive monitoring safety.
McCune EP, Le DQ, Lindholm P, Nightingale KR, Dayton PA, Papadopoulou V. McCune EP, et al. Diving Hyperb Med. 2022 Jun 30;52(2):136-148. doi: 10.28920/dhm52.2.136-148. Diving Hyperb Med. 2022. PMID: 35732286 Free PMC article. Review. - Safety and bio-effects of ultrasound contrast agents.
ter Haar G. ter Haar G. Med Biol Eng Comput. 2009 Aug;47(8):893-900. doi: 10.1007/s11517-009-0507-3. Epub 2009 Jul 14. Med Biol Eng Comput. 2009. PMID: 19597745 - Ultrasound-biophysics mechanisms.
O'Brien WD Jr. O'Brien WD Jr. Prog Biophys Mol Biol. 2007 Jan-Apr;93(1-3):212-55. doi: 10.1016/j.pbiomolbio.2006.07.010. Epub 2006 Aug 8. Prog Biophys Mol Biol. 2007. PMID: 16934858 Free PMC article. Review. - Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice.
Miller DL, Quddus J. Miller DL, et al. Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10179-84. doi: 10.1073/pnas.180294397. Proc Natl Acad Sci U S A. 2000. PMID: 10954753 Free PMC article. - Section 8--clinical relevance. American Institute of Ultrasound in Medicine.
[No authors listed] [No authors listed] J Ultrasound Med. 2000 Feb;19(2):149-68. doi: 10.7863/jum.2000.19.2.149. J Ultrasound Med. 2000. PMID: 10680620 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous